.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Merck
McKesson
Fuji
Citi
Chubb
Colorcon
Mallinckrodt
McKinsey
UBS

Generated: June 22, 2017

DrugPatentWatch Database Preview

Claims for Patent: 7,629,335

« Back to Dashboard

Claims for Patent: 7,629,335

Title:Anti-inflammatory androstane derivative
Abstract: According to one aspect of the invention, there is provided a compound of formula (I) ##STR00001## and solvates thereof. There are also provided compositions containing the compound, processes for preparing it, and its use in therapy.
Inventor(s): Biggadike; Keith (Stevenage, GB), Coote; Steven John (Stevenage, GB), Nice; Rosalyn Kay (Stevenage, GB)
Assignee: Glaxo Group Limited (Greenford, Middlesex, GB)
Application Number:11/428,853
Patent Claims: 1. A pharmaceutical composition comprising dry powder particles which are between 1 and 10 microns in size and which comprise the compound of formula (I) ##STR00026## in the form of an unsolvated Form 1 polymorph, characterized by an XRPD profile having a peak at around 18.9 degrees 2 Theta, wherein said compound of formula (I) is present in the amount of 0.001 to 10% by weight of said pharmaceutical composition.

2. The pharmaceutical composition of claim 1, further comprising lactose.

3. A dry powder inhaler comprising a pharmaceutical composition comprising the compound of formula (I) ##STR00027## in the form of an unsolvated Form 1 polymorph, characterized by an XRPD profile having a peak at around 18.9 degrees 2 Theta, wherein said compound of formula (I) is present in the amount of 0.001 to 10% by weight of said pharmaceutical composition.

4. The dry powder inhaler of claim 3 further comprising lactose.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Express Scripts
Moodys
Fuji
Covington
Accenture
Merck
Mallinckrodt
UBS
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot